Glomerular disease: 'suPAR'-exciting times for FSGS.
Authors:
- J. Ashley JeffersonJJJ. Ashley Jefferson
- Charles E. AlpersCACharles E. Alpers
- 5 February 2013
- journal article
- editorial
- Published by Springer Nature in Nature Reviews Nephrology
- Vol. 9 (3) , 127-8
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Circulating suPAR in Two Cohorts of Primary FSGSJournal of the American Society of Nephrology, 2012
- The calcineurin–NFAT pathway allows for urokinase receptor-mediated beta3 integrin signaling to cause podocyte injuryJournal of Molecular Medicine, 2012
- Usefulness of suPAR as a biological marker in patients with systemic inflammation or infection: a systematic reviewIntensive Care Medicine, 2012
- Serum-soluble urokinase receptor concentration in primary FSGSKidney International, 2012
- Circulating urokinase receptor as a cause of focal segmental glomerulosclerosisNature Medicine, 2011
- Rituximab Targets Podocytes in Recurrent Focal Segmental GlomerulosclerosisScience Translational Medicine, 2011
- Circulating Permeability Factors in Idiopathic Nephrotic Syndrome and Focal Segmental GlomerulosclerosisClinical Journal of the American Society of Nephrology, 2010
- suPAR: The Molecular Crystal BallDisease Markers, 2009
- Modification of kidney barrier function by the urokinase receptorNature Medicine, 2007
- The soluble D2D388-274 fragment of the urokinase receptor inhibits monocyte chemotaxis and integrin-dependent cell adhesionJournal of Cell Science, 2004